Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Quintarelli

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomasClaudia Manuela Arnone, Vinicia Assunta Polito, Angela Mastronuzzi, et al.
Heliyon|December 23, 2024
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational studyAngela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Frontiers in Immunology|May 9, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoringBiagio De Angelis, Maria Luisa D'Amore, Pacôme Lecot, et al.
Cell Death Discovery|November 3, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcomaFrancesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Frontiers in Immunology|January 4, 2021
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe CasesRita Carsetti, Salvatore Zaffina, Eva Piano Mortari, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomasClaudia Manuela Arnone, Vinicia Assunta Polito, Angela Mastronuzzi, et al.
Heliyon|December 23, 2024
Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational studyAngela Mastronuzzi, Rita Carsetti, Maria Antonietta De Ioris, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Frontiers in Immunology|May 9, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoringBiagio De Angelis, Maria Luisa D'Amore, Pacôme Lecot, et al.
Cell Death Discovery|November 3, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcomaFrancesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Frontiers in Immunology|January 4, 2021
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe CasesRita Carsetti, Salvatore Zaffina, Eva Piano Mortari, et al.
Pageof 9